Lipoprotein receptor signalling in atherosclerosis.

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Cellular Signaling

Background:

• The low-density lipoprotein receptor (LDLR) family and scavenger receptors are key regulators of cholesterol homeostasis and cellular uptake of lipoproteins.
• These receptors, including LDLR, LRP1, CD36, and LOX-1, are implicated in atherogenesis.
• Beyond ligand uptake, these receptors modulate cellular functions through signal transduction.

Purpose of the Study:

• To review the signaling pathways of lipoprotein receptors involved in atherosclerosis.
• To focus on the roles of these receptors in vascular cells like macrophages, endothelial cells, smooth muscle cells, and platelets.
• To discuss the human genetics of these receptors and their relevance to cardiovascular disease risk.

Main Methods:

• Literature review of studies on cultured cells and in vivo animal models.
• Analysis of signaling pathways influenced by lipoprotein receptors.
• Examination of human genetic data related to these receptors and cardiovascular disease.

Main Results:

• Lipoprotein receptors significantly influence atherogenesis through diverse signaling pathways.
• These receptors play critical roles in the function of various vascular cell types.
• Genetic variations in these receptors are linked to human cardiovascular disease risks.

Conclusions:

• Lipoprotein receptors are central to vascular cell signaling in atherosclerosis.
• Targeting these receptors and their ligands presents potential for novel therapeutic strategies.
• Further research into the vascular biology of lipoprotein receptors is essential for advancing cardiovascular disease prevention and treatment.